Free shipping on all orders over $ 500

Tyrphostin AG 1296

Cat. No. M3097

All AbMole products are for research use only, cannot be used for human consumption.

Tyrphostin AG 1296 Structure
Synonym:

AG 1296

Size Price Availability Quantity
1mg USD 50  USD50 In stock
5mg USD 95  USD95 In stock
10mg USD 150  USD150 In stock
25mg USD 285  USD285 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Tyrphostin AG 1296 is an inhibitor of PDGFR with IC50 of 0.3-0.5 μM, no activity to EGFR.

Customer Product Validations & Biological Datas
Source Oncol Lett (2015). Figure 2. Tyrphostin AG 1296
Method cell invasion assay
Cell Lines U87MG cells
Concentrations 12.5, 50 or 200 nM
Incubation Time 8 h
Results Statistical analysis demonstrated that the anti.migration effect of tyrphostin AG 1296 in U87MG cells, increased in a dose.dependent manner
Protocol (for reference only)
Cell Experiment
Cell lines Swiss 3T3
Preparation method Seeding cells in 24-well plates (5000 cells/well) in DMEM/10% FCS. A day later, the medium is changed to DMEM/2% FcS with or without growth factors and tyrphostins are added as indicated. Three days later count the cells in a hemocytometer
Concentrations ~50 μM
Incubation time 3 days
Animal Experiment
Animal models
Formulation
Dosages
Administration
Chemical Information
Molecular Weight 266.29
Formula C16H14N2O2
CAS Number 146535-11-7
Solubility (25°C) DMSO 6 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Mingxia Gu, et al. iPSC-endothelial cell phenotypic drug screening and in silico analyses identify tyrphostin-AG1296 for pulmonary arterial hypertension

[2] Min Wang, et al. Platelet-derived growth factor B attenuates lethal sepsis through inhibition of inflammatory responses

[3] Hongwei Li, et al. Tyrphostin AG 1296 induces glioblastoma cell apoptosis in vitro and in vivo

[4] Gabriel M Gordon, et al. A cell-based screening assay to identify pharmaceutical compounds that enhance the regenerative quality of corneal repair

[5] Huan-Yong Che, et al. Additive effect by combination of Akt inhibitor, MK-2206, and PDGFR inhibitor, tyrphostin AG 1296, in suppressing anaplastic thyroid carcinoma cell viability and motility

Related VEGFR/PDGFR Products
Conbercept

Conbercept (KH902) is a monoclonal antibody targeting VEGFRA fused to the IGHG1 Fc fragment. Conbercept is produced by the fusion of the second C-LIKE of FLT1 and the third and fourth C-LIKE of KDR with IGHG1 Fc.

SU5208 

SU5208 inhibits vascular endothelial growth factor receptor-2 (VEGFR2).

VEGFR-IN-1 

VEGFR-IN-1 is a potent angiogenesis inhibitor with IC50s of 0.02, 0.18, 0.24 7.3, and 7 µM for KDR, Flt-1, c-Kit, EGF-R, and c-Src, respectively.

(Z)-Orantinib

(Z)-Orantinib ((Z)-SU6668) is a potent, selective, orally active and ATP competitive inhibitor of Flk‐1/KDR, PDGFRβ, and FGFR1, with IC50s of 2.1, 0.008, and 1.2 µM, respectively.

(Rac)-SAR131675 

(Rac)-SAR131675 is the racemate of SAR131675.

  Catalog
Abmole Inhibitor Catalog




Keywords: Tyrphostin AG 1296, AG 1296 supplier, VEGFR/PDGFR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.